A drug approved to treat eczema provided significant improvement in the symptoms of patients with severe itching diseases that currently have no targeted treatments, according to a new study. The drug ...
Orchid Pharma on Thursday said it has received approval from regulator DCGI to manufacture and market an antibiotic drug for the treatment of complicated urinary tract infections. The Drug Controller ...
Giving the immunotherapy drug pembrolizumab before surgery instead of chemotherapy may help improve cancer-free outcomes for ...
The US FDA has approved once-daily Onyda XR as the first liquid, nonstimulant treatment for attention-deficit/hyperactivity disorder (ADHD).
The company anticipates a successful launch and distribution of Enmetazobactam and its combination with Cefepim to treat ...
Orchid Pharma receives approval from DCGI to manufacture new antibiotic drug for complicated urinary tract infections.
Orchid Pharma has obtained approval from the Drug Controller General of India (DCGI) to manufacture and market an antibiotic ...
In a stock exchange filing, the pharma company said DCGI has approved the manufacturing and marketing of the company’s first ...
Combination of enmetazobactam, invented by scientists associated with Chennai-based pharma firm Orchid Pharma in 2008, and ...
Orchid Pharma rallied 3.92% to Rs 1,037.50 after the company said that it has received an approval from Drugs Controller General of India (DCGI) to manufacture and market its new chemical entity ...
This formulation is indicated for the treatment of complicated Urinary Tract Infections (cUTI) including acute Pyelonephritis ...
Orchid Pharma secures approval for new antibiotic drug combination in India to combat serious infections and antimicrobial ...